112PEFFICACY AND SAFETY OF IMPRIME PGG, A NOVEL INNATE IMMUNE MODULATOR, IN COMBINATION WITH BEVACIZUMAB (BEV), CARBOPLATIN AND PACLITAXEL FOR THE 1ST-LINE TREATMENT OF STAGE IV NSCLC


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles